45 related articles for article (PubMed ID: 30963668)
1. Think twice: a rare calcium sensing receptor mutation and a new diagnosis of familial hypocalciuric hypercalcaemia.
Tellam JJ; Abdulrasool G; Ciin LCH
Endocrinol Diabetes Metab Case Rep; 2020 Jun; 2020():. PubMed ID: 32698162
[TBL] [Abstract][Full Text] [Related]
2. Excluding familial hypocalciuric hypercalcaemia before surgery for primary hyperparathyroidism - a practical evaluation of urinary calcium using a retrospective cohort design.
McAllister J; Arshad MF; Rab E; Balasubramanian SP
Ann R Coll Surg Engl; 2022 Nov; 104(9):710-716. PubMed ID: 35446160
[TBL] [Abstract][Full Text] [Related]
3. One in a billion: a patient with Marfan syndrome and familial hypocalciuric hypercalcaemia.
Ann Tee S; Brennan P; L Mitchell A
Endocrinol Diabetes Metab Case Rep; 2021 Jun; 2021():. PubMed ID: 34152285
[TBL] [Abstract][Full Text] [Related]
4. Sustained activation of renal N-methyl-D-aspartate receptors decreases vitamin D synthesis: a possible role for glutamate on the onset of secondary HPT.
Parisi E; Bozic M; Ibarz M; Panizo S; Valcheva P; Coll B; Fernández E; Valdivielso JM
Am J Physiol Endocrinol Metab; 2010 Nov; 299(5):E825-31. PubMed ID: 20823451
[TBL] [Abstract][Full Text] [Related]
5. Myositis, rhabdomyolysis and severe hypercalcaemia in a body builder.
Ravindran R; Witczak J; Bahl S; Premawardhana LDKE; Adlan M
Endocrinol Diabetes Metab Case Rep; 2020 Jul; 2020():. PubMed ID: 32698126
[TBL] [Abstract][Full Text] [Related]
6. The Diagnosis and Management of Severe Hypercalcaemia: A simplified approach - Report of five cases.
Elshafie OT; Woodhouse NJ
Sultan Qaboos Univ Med J; 2010 Dec; 10(3):388-95. PubMed ID: 21509261
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Alterations in Myotonic Dystrophy Type 1 and Their Correlation with Lipin.
Mateus T; Martins F; Nunes A; Herdeiro MT; Rebelo S
Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33673200
[TBL] [Abstract][Full Text] [Related]
8. Myotonic dystrophy type 2: the 2020 update.
Meola G
Acta Myol; 2020 Dec; 39(4):222-234. PubMed ID: 33458578
[TBL] [Abstract][Full Text] [Related]
9. Fragility fractures and bone mineral density in male patients affected by type 1 and type 2 myotonic dystrophy.
Passeri E; Sansone VA; Sconfienza LM; Messina C; Meola G; Corbetta S
Neuromuscul Disord; 2020 Jan; 30(1):28-34. PubMed ID: 31902642
[TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic characteristics of childhood-onset myotonic dystrophy.
Stokes M; Varughese N; Iannaccone S; Castro D
Muscle Nerve; 2019 Dec; 60(6):732-738. PubMed ID: 31520483
[TBL] [Abstract][Full Text] [Related]
11. Abnormal calcium metabolism in myotonic dystrophy as shown by the Ellsworth-Howard test and its relation to CTG triplet repeat length.
Kinoshita M; Komori T; Ohtake T; Takahashi R; Nagasawa R; Hirose K
J Neurol; 1997 Oct; 244(10):613-22. PubMed ID: 9402536
[TBL] [Abstract][Full Text] [Related]
12. Treatment of bilateral encrusted ureteral stents, large volume renal stones, and ureteral stricture in a complex pediatric patient: a surgical video and case review.
Blake RM; Malhotra N; Gupta M; Khusid JA
Am J Clin Exp Urol; 2023; 11(5):435-442. PubMed ID: 37941644
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Dysfunction in Repeat Expansion Diseases.
Giménez-Bejarano A; Alegre-Cortés E; Yakhine-Diop SMS; Gómez-Suaga P; Fuentes JM
Antioxidants (Basel); 2023 Aug; 12(8):. PubMed ID: 37627588
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Iron Accumulation in Deep Gray Matter in Myotonic Dystrophy Type 1 and 2 Using Quantitative Susceptibility Mapping and R2
Ates S; Deistung A; Schneider R; Prehn C; Lukas C; Reichenbach JR; Schneider-Gold C; Bellenberg B
Front Neurol; 2019; 10():1320. PubMed ID: 31920940
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of calcium metabolism in type 1 myotonic dystrophy.
Hlaing PM; Scott IA; Jackson RV
Intern Med J; 2019 Nov; 49(11):1412-1417. PubMed ID: 30963668
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D, parathyroid hormone and muscle impairment in myotonic dystrophies.
Passeri E; Bugiardini E; Sansone VA; Valaperta R; Costa E; Ambrosi B; Meola G; Corbetta S
J Neurol Sci; 2013 Aug; 331(1-2):132-5. PubMed ID: 23809192
[TBL] [Abstract][Full Text] [Related]
17. Familial hypocalciuric hypercalcaemia: a review.
Christensen SE; Nissen PH; Vestergaard P; Mosekilde L
Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):359-70. PubMed ID: 21986511
[TBL] [Abstract][Full Text] [Related]
18. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
